N/A

Total Visitor

HomeBreaking news

Drugs Controller General of India (DCGI) approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 years. Bharat Biotech to conduct trials in 525 healthy volunteers https://t.co/pp

By newsaddaindia6

May 13, 2021

138

Previous article

कोरोना को लेकर पीएम 20 मई को देश के सभी डीएम से करेंगे बात

Next article

Mike Pompeo: Biden delayed his call with Israeli leadership and restarted funding to the Palestinian Authority through the UN — both signal to Hamas & terrorists in the West Bank that America places less value on our relationship with Israel. It matters who leads.

Anita Choudhary is a freelance journalist. Writing articles for many organizations both in Hindi and English on different political and social issues

Advertisement

spot_img

Related Articles

LEAVE A REPLY Cancel reply

Advertisement Section

- Advertisement -

spot_img

spot_img

spot_img

Latest Articles

Translate »